Dáil debates

Thursday, 9 November 2017

Cannabis for Medicinal Use Regulation Bill 2016 Report: Motion [Private Members]

 

1:10 pm

Photo of Simon HarrisSimon Harris (Wicklow, Fine Gael) | Oireachtas source

I have received two applications from consultants. Neither Deputy Boyd Barrett nor I are consultants. Such applications from doctors will be considered because they know an awful lot more about this issue than Deputy Boyd Barrett or I do. Separately and importantly, we are progressing well with work on the cannabis for medical use access programme. That follows on from a commitment I gave to this House that there are better ways than primary legislation to achieve the same outcome whereby we can have a doctor-led compassionate access progress for medicinal cannabis.

In February, I published the country's first ever policy review on this area, namely, the HPRA's report, Cannabis for Medical Use - A Scientific Review. On foot of the conclusions of the regulatory body, namely, the HPRA - we know what happens in this country when we do not listen to regulators - I announced that I would establish a cannabis for medical use access programme for patients under the care of a consultant, for the following medical conditions, on the basis that they were the medical conditions recommended by the HPRA.

The conditions are spasticity associated with multiple sclerosis, MS, nausea and vomiting associated with chemotherapy, and treatment-resistant epilepsy. I then put together an expert group chaired by the eminent Dr. Máirín Ryan from the Health Information and Quality Authority, HIQA. I established the group in March to develop operational, clinical and practise guidelines for the access programme. There is no point having a piece of paper or report that cannot actually work in a doctor's office. Dr. Ryan brought together an expert group to put the clinical and operational guidelines in place. The group included medical consultants who treat epilepsy, MS, cancer and other serious illnesses, along with patient representatives, pharmacists and health regulators. Considerable work has been undertaken by my officials and my Department to try to put in place the new access programme for medicinal cannabis for the first time ever in the country.

I am pleased to inform the House that the expert group has drafted clinical guidelines. The group has completed the targeted consultation and finalised the guidelines. I thank Dr. Ryan, the patient representatives and the doctors who dedicated an extraordinary amount of time to ensuring that we can have clinical guidelines for a compassionate access programme. Officials in my Department are now working on secondary legislation in the form of three statutory instruments that will underpin the access programme. These statutory instruments will be finalised in December. The expert reference group has made significant progress in developing the clinical guidelines for the programme. However, further work is required in terms of how we source suitable quality-controlled cannabis-based products. We must ensure we have a source for any product that can be accessed under the new scheme.

I have no wish to conflate the issues, but should the point come up during the debate, I inform the House that my colleague, the Minister of State at the Department of Health, Deputy Catherine Byrne, will put in place a review group under the national drugs and alcohol strategy to look at alternatives to criminal sanctions for personal use for some drugs. The intention is to take a health-based approach in respect of drugs and drug addiction. Shortly, the Minister of State will appoint a chairperson. This is a key recommendation of our new national drugs strategy.

I believe the Bill to be well-intentioned. I have no doubt about that or about the commitment, passion and dedication of Deputy Kenny. I do not believe this is a party political issue for him. I accept his bona fides on the matter. However, I have to take heed of the advice available to me as well as the advice, legal and otherwise, available to the Joint Committee on Health. The advice was agreed unanimously by that committee. The Bill would require significant amendment before it can proceed any further. It is in this vein that I hope we can tease out the issues this afternoon.

Comments

No comments

Log in or join to post a public comment.